Aethlon Medical Stock Net Income
| AEMD Stock | USD 0.37 0 0.27% |
Aethlon Medical fundamentals help investors to digest information that contributes to Aethlon Medical's financial success or failures. It also enables traders to predict the movement of Aethlon Stock. The fundamental analysis module provides a way to measure Aethlon Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aethlon Medical stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | -12.2 M | -11.6 M | |
| Net Loss | -12.2 M | -11.6 M | |
| Net Loss | -10.8 M | -11.4 M | |
| Net Loss | (4.86) | (5.10) | |
| Net Income Per E B T | 1.15 | 1.09 |
Aethlon | Net Income |
Aethlon Medical Company Net Income Analysis
Aethlon Medical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Aethlon Medical Net Income | (12.21 M) |
Most of Aethlon Medical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aethlon Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Aethlon Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Aethlon Medical is extremely important. It helps to project a fair market value of Aethlon Stock properly, considering its historical fundamentals such as Net Income. Since Aethlon Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aethlon Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aethlon Medical's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Aethlon Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Aethlon Medical reported net income of (12.21 Million). This is 103.58% lower than that of the Health Care Equipment & Supplies sector and 105.13% lower than that of the Health Care industry. The net income for all United States stocks is 102.14% higher than that of the company.
Aethlon Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aethlon Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aethlon Medical could also be used in its relative valuation, which is a method of valuing Aethlon Medical by comparing valuation metrics of similar companies.Aethlon Medical is currently under evaluation in net income category among its peers.
Aethlon Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Aethlon Medical from analyzing Aethlon Medical's financial statements. These drivers represent accounts that assess Aethlon Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Aethlon Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 5.2M | 24.5M | 21.5M | 7.8M | 4.3M | 4.1M | |
| Enterprise Value | (4.3M) | 14.7M | 5.2M | (5.5M) | (154.6K) | (146.8K) |
Aethlon Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Aethlon Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Aethlon Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Aethlon Medical's value.| Shares | Group One Trading, Lp | 2024-09-30 | 1.2 K | Wells Fargo & Co | 2024-09-30 | 211 | Advisor Group Holdings, Inc. | 2024-09-30 | 149 | Bank Of America Corp | 2024-09-30 | 114 | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 89.0 | Bartlett & Co Wealth Management Llc | 2024-09-30 | 26.0 | Truvestments Capital Llc | 2024-09-30 | 5.0 | Hanson Mcclain Inc | 2024-09-30 | 2.0 | Susquehanna International Group, Llp | 2024-09-30 | 0.0 | Ubs Group Ag | 2024-09-30 | 218.3 K | Geode Capital Management, Llc | 2024-09-30 | 98.4 K |
Aethlon Fundamentals
| Return On Equity | -1.05 | ||||
| Return On Asset | -0.5 | ||||
| Current Valuation | (954.72 K) | ||||
| Shares Outstanding | 13.96 M | ||||
| Shares Owned By Insiders | 0.50 % | ||||
| Shares Owned By Institutions | 3.09 % | ||||
| Number Of Shares Shorted | 203.4 K | ||||
| Price To Earning | (1.14) X | ||||
| Price To Book | 0.85 X | ||||
| Price To Sales | 2.37 X | ||||
| Gross Profit | 574.25 K | ||||
| EBITDA | (11.85 M) | ||||
| Net Income | (12.21 M) | ||||
| Cash And Equivalents | 14.92 M | ||||
| Cash Per Share | 0.65 X | ||||
| Total Debt | 940.32 K | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 9.66 X | ||||
| Book Value Per Share | 2.19 X | ||||
| Cash Flow From Operations | (10.13 M) | ||||
| Short Ratio | 0.98 X | ||||
| Earnings Per Share | (2.79) X | ||||
| Target Price | 3.85 | ||||
| Number Of Employees | 14 | ||||
| Beta | 1.76 | ||||
| Market Capitalization | 5.11 M | ||||
| Total Asset | 8.25 M | ||||
| Retained Earnings | (154.57 M) | ||||
| Working Capital | 4.4 M | ||||
| Current Asset | 817 K | ||||
| Current Liabilities | 1.08 M | ||||
| Net Asset | 8.25 M |
About Aethlon Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aethlon Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aethlon Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aethlon Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports:Check out Aethlon Medical Piotroski F Score and Aethlon Medical Altman Z Score analysis. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.79) | Revenue Per Share 0.236 | Quarterly Revenue Growth 42.782 | Return On Assets (0.50) | Return On Equity (1.05) |
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.